Xeris Biopharma Holdings, Inc
Filings
Newest firstThe annual , the quarterly and the filed between them when something material happens.
- Sep 98-KRegulation FD disclosure7.019.01
- Aug 610-QQuarterly report
- Aug 68-KResults of operations2.029.01
- Jul 3113GPassive stake of 5% or more (13G), filed by Vanguard Capital Management
- Jul 178-KUnregistered sale of shares and other events3.028.01
- Jun 308-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Jun 118-KUnregistered sale of shares and other events3.028.019.01
- Jun 58-KShareholder vote5.07
- May 710-QQuarterly report
- May 78-KResults of operations2.02
- Apr 218-KOfficer or director change5.02
- Mar 210-KAnnual report
- Mar 28-KResults of operations2.029.01
- Feb 268-KRegulation FD disclosure7.019.01
- Jan 88-KResults of operations2.02
- Dec 1, 20258-KRegulation FD disclosure7.019.01
- Nov 6, 202510-QQuarterly report
- Nov 6, 20258-KResults of operations2.02
- Aug 7, 202510-QQuarterly report
- Aug 7, 20258-KResults of operations2.02
- Jun 4, 20258-KShareholder vote5.07
- Jun 3, 20258-KRegulation FD disclosure7.019.01
- May 8, 202510-QQuarterly report
- May 8, 20258-KResults of operations2.029.01
- Mar 28, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Mar 6, 2025S-3Shelf registration
- Mar 6, 202510-KAnnual report
- Mar 6, 20258-KResults of operations2.029.01
- Feb 24, 20258-KOfficer or director change and Regulation FD disclosure5.027.019.01
- Jan 10, 20258-KResults of operations2.029.01